Identification of an inflammatory phenotype with higher likelihood of progression in OA: Analysis of womac pain sub-questions, C3M and U-CTX-II from two phase 3 randomized clinical trials with treatment of symptomatic knee osteoarthritis  by Bay-Jensen, A.C. et al.
Abstracts / Osteoarthritis and Cartilage 23 (2015) A26eA81A7078
IDENTIFICATION OF AN INFLAMMATORY PHENOTYPE WITH HIGHER
LIKELIHOOD OF PROGRESSION IN OA: ANALYSIS OF WOMAC PAIN
SUB-QUESTIONS, C3M AND U-CTX-II FROM TWO PHASE 3
RANDOMIZED CLINICAL TRIALS WITH TREATMENT OF
SYMPTOMATIC KNEE OSTEOARTHRITIS
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Purpose: There are three main tissues remodeled as part of osteo-
arthritis (OA); cartilage, bone and the synovial membrane, which may
represent separate phenotypes that needs to be treated differently.
Recent data has shown that type II collagen degradation (CTX-II) is a
biomarker of cartilage and subchondral turnover. C3M is a biomarker of
synovial inﬂammation and turnover. It is estimated that about 10-30%
of OA patients have synovitis. The aim of the study was identify dif-
ferent subtypes of OA related to progression.
Methods: Fasting serum (n¼767) and urine (n¼620) samples were
collected at baseline from patients with painful knee OA participating in
the placebo arms of two phase III RCTs (NCT00486434 and
NCT00704847). Serum C3M (MMP-derived type III collagen neo-epit-
ope [Nordic Bioscience, Denmark]) and creatinine-corrected urinary
CTX-II (type II collagen C-terminal telopeptide [IDS PLC, United King-
dom]) were measured. The relationship between the biomarkers and
the 5 WOMAC pain subscale questions of the baseline-reported
WOMAC pain level, using the sum of target and non-target knee, were
analyzed: A; during walking on a ﬂat surface, B; using stairs (up or
down), C; at night while in bed, D; sitting or lying and E; while standing.
Joint space width was analyzed at baseline and after 24month. The data
were analyzed by Spearman’s correlations on log-transformed data and
by backward multiple regression analysis, where WOMAC or radio-
graphic scores were set as the dependent variable and biomarkers, age,
gender and BMI as covariates.
Results: Levels of CTX-II signiﬁcantly correlated withWOMACwith all 5
sub-questions (p<0.01), while level of C3M was correlated with ques-
tion B and E (p<0.05). When adjusting for age, BMI, and gender, CTX-II
remained signiﬁcantly associated with all sub-questions: A) r¼0.20,
p<0.0001; B) r¼0.16, p¼0.0005; C) r¼0.11, p¼0.017; D) r¼0.13,
p¼0.0046; and E) r¼0.17, p¼0.0002. C3M became non-signiﬁcant; B)
r¼0.08, p¼0.063 and E) r¼0.08, p¼0.069. CTX-II was signiﬁcantly cor-
related to the mean JSW of the two knees (r¼-0.17, p<0.0001), whereas
C3M was signiﬁcantly correlated to joint space narrowing of the target
knee (r¼0.11, p¼0.013).
Conclusions: Diagnostically, urinary CTX-II was associated with all
types of pain. Most prominent with WOMAC sub-question A, walking
on a ﬂat surface, which may indicate that CTX-II is related to pain
coming from continuous skeletal load - supported by the strong cor-
relation with JSW and previous data suggestion origins of subchondral
bone turnover and articular cartilage. C3M, which are released in syn-
ovitis, was weakly correlated with B and E, using stairs and standing
still, respectively. C3M was correlated to progression indicating that
patients with elevated C3M and consequently synovial inﬂammation
had a higher likelihood of being a progressor. These biomarkers may
assist in identiﬁcation of the inﬂammation driven OA phenotype, which
needs to be treated different than non-inﬂammatory OA.
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IMPROVED PHENOTYPE DEFINITIONS OF OA IN GENETIC
ASSOCIATION STUDIES HIGHLIGHT A STRUCTURAL ROLE FOR A
COMMON VARIANT IN LRCH1
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Purpose: Osteoarthritis (OA) has a strong genetic component but the
success of previous genetic association studies has been restricted due
to insufﬁcient sample sizes and phenotype heterogeneity. Differences in
ascertainment criteria along with the highly heterogeneous clinical
manifestations of OA have been proposed as likely factors behind the
paucity of replication for genetic determinants of OA. The aim of our
study is to identify hip OA susceptibility variants by examining a set ofmore homogeneous, radiographically-derived OA endophenotypes
relating to speciﬁc anatomic pattern of joint involvement.
Methods: Hip OA subjects comprised in total 2,118 unrelated individuals
of European ancestry from the arcOGEN genome-wide association study
(GWAS). Inclusion criteriawere radiographic evidence of hip OA (Kellgren
Lawrence (KL)  2) and secondly, a set of minimum radiographic
requirements deﬁned as an antero-posterior (AP) view of the degenerate
hip joint. Hip OA pattern was classiﬁed using standard photographic
atlases as superior, axial, medial and concentric joint space narrowing.
1,817 cases had GWAS data on Illumina 610k and 301 cases had GWAS
data on the HumanOmniExpress platform. We used 6,500 population-
based, publically-available controls from the UK. Following 1000
Genomes-based imputation and stringent quality control we carried out
association analyses at ~7million variants using the score test under an
additive model and meta-analyses with the ﬁxed-effects model. We car-
ried out 2 types of association analyses: GWAS meta-analysis within OA
cases by comparing i) hip OA cases characterised by axial/medial femoral
head migration vs. all other hip OA cases and conversely hip OA cases
characterised by superior femoral head migration vs. all other hip OA
cases; and ii) GWAS of 1,817 hip OA cases stratiﬁed by anatomic pattern of
joint involvement against publically-available controls.
Results: In theGWASmeta-analysis carriedout acrossOAcaseswithaxial/
medial femoral head migration vs. all other hip OA cases the most sig-
niﬁcant association was observed for rs754106 in intron 1 of the LRCH1
gene (for allele T OR[CIs]¼1.46[1.26-1.68]; p¼2.9x10-7). Adjustment for
genderdidnot attenuate the signal (p¼5.7x10-6). Evidence for association
was strong and consistent across bothGWASsetsdespite the small sample
size of the second study (p¼1.1x10-5, N¼425/1392; p¼0.004, N¼76/225).
Conversely in the GWAS meta-analysis carried out across OA cases with
superior femoral head migration vs. the rest (N¼1469/647) rs754106 is
also the most signiﬁcant locus (p¼1.1x10-7) but the T allele is protective
(OR¼0.7). In the association analysis of hip OA patients with axial/medial
femoral head migration vs population-based controls we still ﬁnd strong
evidence for association at rs754106 (p¼0.00015, OR 1.31[1.13-1.5]) but
when we analyse all hip OA cases together vs. the same control set the
signal is fully attenuated (p¼ 0.89).
Rs754106 is in intron 1 of Leucine-Rich Repeats And Calponin Homology
(CH) Domain Containing 1 (LRCH1/CHDC1) gene. Genetic associations
with knee OA at variants spanning intron 1 of LRCH1 were previously
reported but the most signiﬁcant association was observed at rs912428
(for allele T OR[CIs]¼1.44[1.18-1.79]; p<5x10-4, N¼1978/1798) which is
located 15kb away from rs754106 (D’¼1, r2¼0.242). Similar trends in
allele frequencies were observed for samples with hand and hip OA but
were not signiﬁcant. Subsequent publications examining the role of this
variant in knee or hip OA yielded conﬂicting results while a synthesis of
genetic association studies to date reported an OR of 1.17 with nominal
signiﬁcance and moderate heterogeneity. Our ﬁndings indicate that the
paucity of replication at this locus stems from the differences between
prevalence of pattern of joint involvement in the different cohorts.
Conclusions: By partitioning the hip OA phenotype according to speciﬁc
anatomic pattern of joint involvement we detect a common variant in
LRCH1 and highlight the structural role of this gene in OA. We conclude
that in a highly heterogeneous disease like OA precise phenotype deﬁ-
nition is crucial for empowering the detection and replication of OA
susceptibility loci and can provide important insights into the speciﬁc
processes of OA.
80
JOINT RELATED NEUROPATHIC PAIN IS ASSOCIATED WITH LOSS OF
JOINT SPECIFIC FUNCTION AND QUALITY OF LIFE WITHIN HIP AND
KNEE OSTEOARTHRITIS PATIENTS
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Purpose: In the past decade it became clear that Osteoarthritis (OA)-pain
is not solely nociceptive-driven. Changes within the peripheral and
central nervous system are probably accountable for accessory pain
ampliﬁcation and sensitization. It is believed that central sensitisation
(CS) in combination with peripheral nerve disruption may manifest in
OA-painwith neuropathic features. Based on previous studies it’s known
that about 20-37% of the hip/knee OA patients possess a possible or likely
neuropathic pain (NP) phenotype (painDETECT-score >12). As known,
